## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
Molecular characterization of A1 and A2a adenosine receptors
β Scribed by Dr. Kenneth A. Jacobson; Philip J. M. van Galen; Xiao-Duo Ji; Vickram Ramkumar; Mark E. Olah; Gary L. Stiles
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 491 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
2Ξ²,3Ξ²,4Ξ±(S\*) ]-4-[7- [[1-[(3-chloro-2-thienyl)methyl]propylamino]-3Himidazo [4,5-b]pyridin-3-yl]-N-ethyl-2,3-dihydroxy cyclopentanecarboxamide) is a novel cardioprotective adenosine agonist with the following order of affinity at adenosine receptors: A 1 > A 2A > A 3 . Agonism at A 1 receptors was
A 2A adenosine receptors are expressed on immune cells including neutrophils, lymphocytes, eosinophils, monocytes/macrophages, and mast cells. Activation of A 2A receptors on these cells stimulates an increase in [cyclic AMP] i and causes a diminution of inflammatory responses. In mast cells, degran
Adenosine is involved as an endogenous modulator of nerve and glial cell functions in pathological processes occurring in conditions of hypoxia/hypoglycemia and also in neurodegenerative diseases. Thus, adenosine levels rise rapidly in the brain areas affected by ischemic insult; it reduces excitato
Recent studies have clearly shown that the adenosine A 2A receptors are present in a variety of peripheral tissues, including smooth muscle cells, heart muscle and coronary arteries, and human circulating blood elements. This paper reviews the studies performed by our research group on the A 2A rece